GLENMEDE TRUST CO NA - MEDICINES CO ownership

MEDICINES CO's ticker is MDCO and the CUSIP is 584688105. A total of 169 filers reported holding MEDICINES CO in Q2 2013. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
GLENMEDE TRUST CO NA ownership history of MEDICINES CO
ValueSharesWeighting
Q1 2020$66,0000.0%7840.0%0.00%
Q4 2019$66,000
-71.6%
784
-83.1%
0.00%
-100.0%
Q3 2019$232,000
+43.2%
4,645
+4.0%
0.00%0.0%
Q2 2019$162,000
+1146.2%
4,465
+836.1%
0.00%
Q1 2019$13,000
+44.4%
4770.0%0.00%
Q4 2018$9,000
-35.7%
477
+29.3%
0.00%
Q2 2018$14,000
+55.6%
369
+3.4%
0.00%
Q1 2018$9,0000.0%3570.0%0.00%
Q4 2017$9,000
+50.0%
357
+95.1%
0.00%
Q3 2017$6,000
-25.0%
1830.0%0.00%
Q2 2017$8,0000.0%1830.0%0.00%
Q1 2017$8,000
-11.1%
183
-45.7%
0.00%
Q1 2016$9,0000.0%337
+30.6%
0.00%
Q4 2015$9,0000.0%2580.0%0.00%
Q3 2015$9,000
+200.0%
258
+61.2%
0.00%
Q2 2015$3,000
-99.2%
160
-98.5%
0.00%
-100.0%
Q4 2013$398,000
+15.0%
10,3260.0%0.00%0.0%
Q3 2013$346,000
+9.1%
10,3260.0%0.00%0.0%
Q2 2013$317,000
-7.8%
10,3260.0%0.00%
-86.7%
Q1 2013$344,000
-67.0%
10,326
-74.5%
0.03%
-73.7%
Q3 2012$1,044,000
+48.5%
40,450
+23.4%
0.11%
+200.0%
Q1 2012$703,000
+151.1%
32,780
+117.5%
0.04%
-2.6%
Q4 2011$280,000
+1.1%
15,070
-19.1%
0.04%
-15.2%
Q3 2011$277,000
-9.8%
18,6370.0%0.05%
+7.0%
Q2 2011$307,000
+16.7%
18,6370.0%0.04%
-4.4%
Q4 2010$263,000
-21.3%
18,637
-20.9%
0.04%
-29.7%
Q3 2010$334,000
+86.6%
23,5660.0%0.06%
+68.4%
Q2 2010$179,000
-39.9%
23,566
-13.0%
0.04%
-37.7%
Q3 2009$298,000
+31.3%
27,0990.0%0.06%
+15.1%
Q2 2009$227,000
+42.8%
27,099
+84.2%
0.05%
+17.8%
Q1 2009$159,000
-26.4%
14,7120.0%0.04%
-18.2%
Q4 2008$216,000
-36.7%
14,7120.0%0.06%
-16.7%
Q3 2008$341,000
+17.2%
14,7120.0%0.07%
+29.4%
Q2 2008$291,000
+98.0%
14,712
+217.1%
0.05%
+104.0%
Q4 2007$147,000
-40.5%
4,640
-53.1%
0.02%
-35.9%
Q1 2007$247,000
+68.0%
9,885
+113.0%
0.04%
+56.0%
Q4 2006$147,0004,6400.02%
Other shareholders
MEDICINES CO shareholders Q2 2013
NameSharesValueWeighting ↓
Sarissa Capital Management LP 4,202,000$356,917,00029.62%
SYQUANT CAPITAL SAS 505,030$42,897,00022.09%
Moab Capital Partners 521,987$44,338,00017.51%
Antipodean Advisors LLC 321,000$27,266,00015.60%
RAMIUS ADVISORS LLC 419,826$35,660,00015.34%
DLD Asset Management, LP 3,275,900$278,255,00015.00%
Foresite Capital Management IV, LLC 403,217$34,249,00014.78%
WHITE SQUARE CAPITAL LLP 239,331$20,329,00014.70%
Davide Leone & Partners Investment Co Ltd. 1,146,192$97,358,00012.50%
Quad Capital Management Advisors LLC 8,640$734,00011.19%
View complete list of MEDICINES CO shareholders